Cartesian Therapeutics, Inc. financial data

Symbol
RNAC on Nasdaq
Industry
Pharmaceutical Preparations
Location
7495 New Horizon Way, Frederick, MD
State of incorporation
DE
Fiscal year end
December 31
Former names
SELECTA BIOSCIENCES INC (to 11/13/2023)
Latest financial report
10-K - Q4 2024 - Mar 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 636 % +107%
Debt-to-equity -797 % -196%
Return On Equity 138 % -62.3%
Return On Assets -19.8 % +84.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.9M shares -84%
Common Stock, Shares, Outstanding 25.8M shares +377%
Entity Public Float 194M USD +50.5%
Common Stock, Value, Issued 3K USD +200%
Weighted Average Number of Shares Outstanding, Basic 17.3M shares +234%
Weighted Average Number of Shares Outstanding, Diluted 17.4M shares +236%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 387K USD -94.1%
Revenue from Contract with Customer, Excluding Assessed Tax 38.3M USD +47.2%
Research and Development Expense 45.1M USD -36.7%
General and Administrative Expense 30.1M USD -25.5%
Operating Income (Loss) -43.9M USD +49.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9M USD -9.59%
Net Income (Loss) Attributable to Parent -77.4M USD +64.8%
Earnings Per Share, Basic -4.48 USD/shares +91%
Earnings Per Share, Diluted -4.49 USD/shares +91%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 213M USD +176%
Accounts Receivable, after Allowance for Credit Loss, Current 872K USD -85.1%
Assets, Current 217M USD +139%
Property, Plant and Equipment, Net 9.91M USD +369%
Operating Lease, Right-of-Use Asset 5.54M USD -45%
Goodwill 48.2M USD 0%
Other Assets, Noncurrent 518K USD
Assets 435M USD +42.6%
Accounts Payable, Current 288K USD -90.9%
Employee-related Liabilities, Current 3.53M USD -19.5%
Accrued Liabilities, Current 12.1M USD -18%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 23M USD -66.3%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 16.1M USD +1.82%
Operating Lease, Liability, Noncurrent 11.1M USD +26.7%
Liabilities 442M USD -0.64%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.62M USD -0.46%
Retained Earnings (Accumulated Deficit) -692M USD -12.6%
Stockholders' Equity Attributable to Parent -6.8M USD +98.5%
Liabilities and Equity 435M USD +42.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.9M USD -81.6%
Net Cash Provided by (Used in) Financing Activities 43M USD +28780%
Net Cash Provided by (Used in) Investing Activities -602K USD -102%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 25.8M shares +377%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 26.5M USD +36%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 214M USD +174%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 248M USD +99.4%
Deferred Tax Assets, Gross 275M USD +80.2%
Operating Lease, Liability 14M USD +27.6%
Depreciation 1.2M USD +71.4%
Payments to Acquire Property, Plant, and Equipment 602K USD +363%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -77.4M USD +64.8%
Lessee, Operating Lease, Liability, to be Paid 18.4M USD +37.1%
Property, Plant and Equipment, Gross 12.3M USD +56.5%
Operating Lease, Liability, Current 2.85M USD +31.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.54M USD +43.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.65M USD +18.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +20.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.46M USD +78.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.35M USD +33.8%
Deferred Tax Assets, Operating Loss Carryforwards 44.1M USD +47.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 9.43M shares -0.26%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.31M USD -23.3%
Operating Lease, Payments 761K USD +16.5%
Additional Paid in Capital 690M USD +285%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 6.58M USD -74.5%
Interest Expense 2.03M USD -35.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%